https://prabadinews.com/
  • October 9, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

Updated Diabetes Guidelines Prioritize SGLT-2 and GLP-1 Medications to Reduce Cardiovascular, Kidney Risk

Updated Diabetes Guidelines Prioritize SGLT-2 and GLP-1 Medications to Reduce Cardiovascular, Kidney Risk

An international BMJ panel recommended broader use of SGLT-2 inhibitors and GLP-1 receptor agonists.

administrator

Related Articles